Arrowhead
  • Home
  • About
    • Management
    • Board of Directors
    • Scientific Advisors
  • Programs
    • Pipeline Chart
    • About RNAi
    • About Obesity
  • Technology
    • Nucleic Acid Delivery
    • RNAi
    • Homing Peptides
    • Publications
  • News
    • Press Releases
    • Webcasts
    • Presentations
    • Arrowhead in the News
  • Investor Relations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Presentations and Events
    • FAQ
    • Contact Investor Relations
  • Careers
  • Contact
 
  • Stock Information
  • SEC Filings
  • Corporate Profile
  • Corporate Governance

    Code of Corporate Conduct

    Audit Committee

    Nomination Committee Charter

    Compensation Committee Charter

  • Presentations and Events
  • FAQ
  • Contact Investor Relations
Filing Description Date Filed ↓ Size
424B3 424B3 - Prospectus [Rule 424(b)(3)] Feb 2, 2012 96 KB
EFFECT EFFECT - Notice of Effectiveness Jan 31, 2012 1 KB
S-3/A S-3/A [Amend] - Registration statement under Securities Act of 1933 Jan 26, 2012 156 KB
424B3 424B3 - Prospectus [Rule 424(b)(3)] Jan 13, 2012 87 KB
424B3 424B3 - Prospectus [Rule 424(b)(3)] Jan 13, 2012 83 KB
DEF 14A DEF 14A - Other definitive proxy statements Jan 12, 2012 1 MB
EFFECT EFFECT - Notice of Effectiveness Jan 11, 2012 1 KB
EFFECT EFFECT - Notice of Effectiveness Jan 11, 2012 1 KB
S-3/A S-3/A [Amend] - Registration statement under Securities Act of 1933 Jan 9, 2012 146 KB
S-3/A S-3/A [Amend] - Registration statement under Securities Act of 1933 Jan 9, 2012 142 KB
3 3 - Initial statement of beneficial ownership of securities Jan 6, 2012 4 KB
 
2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998